Home
About
Overview
Sharing Data
ORCID
Help
History (61)
Polyporales
TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
Weight loss and incidence of diabetes with the Veterans Health Administration MOVE! lifestyle change programme: an observational study.
Corrigendum: Cystathionine ß-Synthase Is Necessary for Axis Development in vivo.
Why, why, why de-lupus (does so badly in clinical trials).
See All 61 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Why, why, why de-lupus (does so badly in clinical trials).
Why, why, why de-lupus (does so badly in clinical trials). Expert Rev Clin Immunol. 2016; 12(2):95-8.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antirheumatic Agents
Clinical Trials as Topic
Drug Therapy, Combination
Humans
Lupus Erythematosus, Systemic
Recombinant Fusion Proteins
Rituximab
Treatment Failure
authors with profiles
Joan Merrill